IGI, INC. IG: IGI today proudly announced that it has entered into a product development and manufacturing agreement with Universe Cosmetics Inc., to develop cosmetic and skin care products using its patented Novasome(R) micro encapsulation delivery technology.
Universe Cosmetics, Inc. distributes a complete line of cosmetics products through the brand name of Arpeggio Professional Makeup and TKOUSA Cosmetics, a fun and trendy line targeted to the Echo generation.
Arpeggio professional products are being distributed in 650 beauty salons and spas, Marriott spas, and 170 high-end boutique stores.
TKOUSA has current distribution in CVS, Longs Drugs, and 850 independent drug stores.
Arpeggio Cosmetics website http://www.arpeggiocosmetics.com/.
"IGI's patented Novasome(R) micro-encapsulation delivery technology was chosen by Universe Cosmetics because of enhanced product stability and controlled release in a non-irritating, deep penetrating, moisturizing delivery system", stated Frank Gerardi, IGI's Chairman and CEO.
IGI is applying its patented Novasome(R) microencapsulation technologies to deliver pharmaceuticals, dermaceuticals, cosmetics, skin care, nutrients and other industrial products. Novasomes(R) drive large molecules deep into the skin in a moisturizing non-irritating delayed release cream.
The statements in this release by Frank Gerardi are forward-looking statements that are based on current expectations, estimates and projections about the Company's business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks and uncertainties that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including the following: changes in demand for the Company's products, product mix, the timing of customer orders or deliveries, the impact of competitive products and pricing, constraints on supplies of critical components, excess or shortage of production capacity and other risks discussed from time to time in the Company's SEC filings. In addition, such statements could be affected by general industry and market conditions and growth rates, and general domestic and international economic conditions. Such forward-looking statements speak only as of the date on which they are made and the Company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of the release.
Contact Information: IGI, Inc. Frank Gerardi, 856-697-1441 www.askigi.com
© 2004 BusinessWire